Transparency in Canadian public drug advisory committees
Year of publication: |
2014
|
---|---|
Authors: | Rosenberg-Yunger, Zahava R.S. ; Bayoumi, Ahmed M. |
Published in: |
Health Policy. - Elsevier, ISSN 0168-8510. - Vol. 118.2014, 2, p. 255-263
|
Publisher: |
Elsevier |
Subject: | Qualitative research | Resources allocation | Transparency | Drug policy |
-
Viewing "open strategy" as a viable approach to the management of strategy
Goldman, Geoff A., (2021)
-
Seizov, Ognyan, (2021)
-
Folding and unfolding : balancing openness and transparency in open source communities
Shaikh, Maha, (2016)
- More ...
-
The Measurement of Contingent Valuation for Health Economics
Bayoumi, Ahmed M., (2004)
-
Clinical and Economic Implications of Non-Adherence to HAART in HIV Infection
Scalera, Alissa, (2002)
-
Healthcare sustainability and the challenges of innovation to biopharmaceuticals in Canada
Rosenberg-Yunger, Zahava R.S., (2008)
- More ...